Body mass index in male patients with COPD: Correlation with low attenuation areas on CT

Thorax

Volumn 64, Issue 1, 2009, Pages 20-25

  Ogawa, E ^a,e   Nakano, Y ^b   Ohara, T ^a   Muro, S ^a   Hirai, T ^a   Sato, S ^a   Sakai, H ^a   Tsukino, M ^c   Kinose, D ^a   Nishioka, M ^a   Niimi, A ^a   Chin, K ^a   Pare P D ^d   Mishima, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Hikone Municipal Hospital   (Japan)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION COEFFICIENT; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RADIATION ATTENUATION; SUBCUTANEOUS FAT;

EID: 58349119129     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.097543     Document Type: Article

References (40)

1. Bethesda M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated. 2006. http://www.goldcopd.com (accessed 5 November 2008).
2. Paré PD, Brooks LA, Bates J, et al. Exponential analysis of the lung pressure-volume curve as a predictor of pulmonary emphysema. Am Rev Respir Dis 1982;126:54-61.
3. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
4. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-8.
5. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005;171:142-6.
6. Nakano Y, Müller NL, King GG, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002;122:271S-5S.
7. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347- 60.
8. Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000;6:110-15.
9. Annotator. Blue bloater: pink puffer. Br Med J 1968;2:677.
10. Mishima M, Hirai T, Jin Z, et al. Standardization of low attenuation area versus total lung area in chest X-ray CT as an indicator of chronic pulmonary emphysema. Front Med Biol Eng 1997;8:79-86.
11. Berger P, Perot V, Desbarats P, et al. Airway wall thickness in cigarette smokers: quantitative thin-section CT assessment. Radiology 2005;235:1055-64.
12. Montaudon M, Berger P, Cangini-Sacher A, et al. Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 2007;242:573-81.
13. Orlandi I, Moroni C, Camiciottoli G, et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005;234:604-10.
14. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154:187-92.
15. Madani A, De Maertelaer V, Zanen J, et al. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification-comparison with macroscopic and microscopic morphometry. Radiology 2007;243:250-7.
16. Madani A, Zanen J, de Maertelaer V, et al. Pulmonary emphysema: objective quantification at multi-detector row CT-comparison with macroscopic and microscopic morphometry. Radiology 2006;238:1036- 43.
17. Kitaguchi Y, Fujimoto K, Kubo K, et al. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006;100:1742-52.
18. Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007;62:932-7.
19. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med 2008;102:367-76.
20. Miniati M, Monti S, Stolk J, et al. Value of chest radiography in phenotyping chronic obstructive pulmonary disease. Eur Respir J 2008;31:509-15.
21. Fujimoto K, Kitaguchi Y, Kubo K, et al. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology 2006;11:731-40.
22. Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186:157-65.
23. Hugh O, Schutz Y, Fitting JW. The daily energy expenditure in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:294-300.
24. Oecramer M, De Benedetto F, Del Ponte A, et al. Systemic effects of COPD. Respir Med 2005;99:S3-10.
25. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
26. Ferreira IM, Brooks D, Lacasse Y, et al. Nutritional support for individuals with COPD: a meta-analysis. Chest 2000;117:672-8.
27. Steiner MC, Barton RL, Singh SJ, et al. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2003;58:745-51.
28. Wilson DO, Rogers RM, Sanders MH, et al. Nutritional intervention in malnourished patients with emphysema. Am Rev Respir Dis 1986;134:672-7.
29. Stein JFH. Pathological anatomy of hunger disease. In: Winick M, ed. Hunger disease: studies by the Jewish physicians in the Warsaw Ghetto: current concepts in nutrition. New York: John Wiley & Sons, 1979.
30. Gail DB, Massaro GD, Massaro D. Influence of fasting on the lung. J Appl Physiol 1977;42:88-92.
31. Harkema JR, Mauderly JL, Gregory RE, et al. A comparison of starvation and elastase models of emphysema in the rat. Am Rev Respir Dis 1984;129:584-91.
32. Coxson HO, Chan IH, Mayo JR, et al. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 2004;170:748-52.
33. Cano NJ, Roth H, Court-Ortune I, et al. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J 2002;20:30-7.
34. Man SF, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-53.
35. Sin DD, Man SF. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005;83:8-13.
36. Schols AM, Creutzberg EC, Buurman WA, et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1220-6.
37. Cohen Rl, Marzouk K, Berkoski P, et al. Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema. Chest 2003;124:1365-72.
38. Yuan R, Mayo JR, Hogg JC, et al. The effects of radiation dose and CT manufacturer on measurements of lung densitometry. Chest 2007;132:617-23.
39. Okazawa M, Paré PD, Lambert RK. Compliance of peripheral airways deduced from morphometry. J Appl Physiol 2000;89:2373-81.
40. Greaves LJ, Richardson LA. Tobacco use, women, gender, and chronic obstructive pulmonary disease: are the connections being adequately made? Proc Am Thorac Soc 2007;4:675-9.